Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
(9 sites) United States
University of California Davis Comprehensive Cancer Center, Sacramento, California Moffitt Cancer Center-International Plaza, Tampa, Florida Moffitt Cancer Center - McKinley Campus, Tampa, Florida Moffitt Cancer Center, Tampa, Florida Moffitt Cancer Center at Wesley Chapel, Wesley Chapel, Florida Case Western Reserve University, Cleveland, Ohio Ohio State University Comprehensive Cancer Center, Columbus, Ohio University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania University of Virginia Cancer Center, Charlottesville, Virginia